Signals
Parkinson’s Is Trying to Vaccinate Against Progression
A Phase II alpha-synuclein vaccine generated antibodies in every treated participant and reached the cerebrospinal fluid. The immune response is real. Whether it changes Parkinson’s disease is still unanswered.
Hepatitis Elimination Is Still Losing Patients Before Diagnosis
Diabetic Eye Screening Is Becoming Risk-Based
Abu Dhabi Puts Rare Eye Gene Therapy on the Regional Map
AI Eye Screening Has an Image Quality Problem
AI Retinal Screening Moves Into the Diabetes Clinic
India Turns AI Eye Screening Into Public-Health Infrastructure
Africa’s Cardiovascular Decade Is a System-Design Problem
Inherited Lipid Screening Becomes Europe’s Prevention Test
ATTR Gene Editing Restarts, But Safety Becomes the Access Question
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.